Document Detail


Effects of interleukin-18 on cardiac fibroblast function and gene expression.
MedLine Citation:
PMID:  21050772     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Fibroblasts are the primary cell type responsible for synthesis and remodeling of the extracellular matrix in the heart. A number of factors including growth factors, hormones and mechanical forces have been identified that modulate the production of extracellular matrix by cardiac fibroblasts. Inflammatory mediators including pro-inflammatory cytokines and chemokines also impact fibrosis of the heart. Recent studies have illustrated that interleukin-18 promotes a pro-fibrotic response in cardiac fibroblasts; however the effects of this cytokine on other aspects of fibroblast function have not been examined. While fibroblasts have long been known for their role in production and remodeling of the extracellular matrix, other functions of these cells are only now beginning to be appreciated. We hypothesize that exposure to interleukin-18 will stimulate other aspects of fibroblast behavior important in myocardial remodeling including proliferation, migration and collagen reorganization. Fibroblasts were isolated from adult male rat hearts and bioassays performed to determine the effects of interleukin-18 on fibroblast function. Treatment of fibroblasts with interleukin-18 (1-100ng/ml) resulted in increased production of extracellular matrix components and remodeling or contraction of three-dimensional collagen scaffolds by these cells. Furthermore, exposure to interleukin-18 stimulated fibroblast migration and proliferation. Treatment of heart fibroblasts with interleukin-18 resulted in the rapid activation of the c-Jun N-terminal kinase (JNK) and phosphoinositide 3-kinase (PI3-kinase) pathways. Studies with pharmacological inhibitors illustrated that activation of these pathways is critical to interleukin-18 mediated alterations in fibroblast function. These studies illustrate that interleukin-18 plays a role in modulation of cardiac fibroblast function and may be an important component of the inflammation-fibrosis cascade during pathological myocardial remodeling.
Authors:
Charity Fix; Kellie Bingham; Wayne Carver
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2010-11-02
Journal Detail:
Title:  Cytokine     Volume:  53     ISSN:  1096-0023     ISO Abbreviation:  Cytokine     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2010-11-18     Completed Date:  2011-02-28     Revised Date:  2012-01-04    
Medline Journal Info:
Nlm Unique ID:  9005353     Medline TA:  Cytokine     Country:  United States    
Other Details:
Languages:  eng     Pagination:  19-28     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier Ltd. All rights reserved.
Affiliation:
Department of Cell Biology and Anatomy, University of South Carolina, School of Medicine, Columbia, SC 29209, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Biological Assay
Cell Movement / drug effects
Cell Proliferation / drug effects
Cell Separation
Collagen / metabolism
Enzyme Activation / drug effects
Extracellular Matrix Proteins / genetics,  metabolism
Fibroblasts / cytology,  drug effects*,  enzymology,  metabolism*
Gels
Gene Expression Regulation / drug effects*
Integrins / genetics,  metabolism
Interleukin-18 / pharmacology*
JNK Mitogen-Activated Protein Kinases / metabolism
Male
Matrix Metalloproteinase 2 / metabolism
Myocardium / cytology*
Phosphatidylinositol 3-Kinase / metabolism
Proto-Oncogene Proteins c-akt / metabolism
Rats
Rats, Sprague-Dawley
Signal Transduction / drug effects
Grant Support
ID/Acronym/Agency:
HL0803441/HL/NHLBI NIH HHS; R01 HL083441-04/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Extracellular Matrix Proteins; 0/Gels; 0/Integrins; 0/Interleukin-18; 9007-34-5/Collagen; EC 2.7.1.137/Phosphatidylinositol 3-Kinase; EC 2.7.11.1/Proto-Oncogene Proteins c-akt; EC 2.7.11.24/JNK Mitogen-Activated Protein Kinases; EC 3.4.24.24/Matrix Metalloproteinase 2

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Tear cytokines and chemokines in patients with Demodex blepharitis.
Next Document:  Effects of muscular activation patterns on the ankle joint stabilization: An investigation under dif...